002432 九安医疗
2023/06 - 中期2022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)3.974142.95638.20013.6604.146
总资产报酬率 ROA (%)3.585124.93828.44411.0183.453
投入资产回报率 ROIC (%)3.732131.51231.02110.3593.659

边际利润分析
销售毛利率 (%)66.20679.60463.47556.30728.790
营业利润率 (%)47.91269.58641.82311.8802.908
息税前利润/营业总收入 (%)40.11868.58641.81012.8732.759
净利润/营业总收入 (%)41.83262.64138.98111.7923.831

收益指标分析
经营活动净收益/利润总额(%)93.291103.41194.976181.590-891.254
价值变动净收益/利润总额(%)35.580-1.2767.610-7.6771,672.651
营业外收支净额/利润总额(%)0.119-0.296-0.2920.486-11.723

偿债能力分析
流动比率 (X)20.92216.5192.7543.3567.583
速动比率 (X)20.38015.6462.1502.7936.181
资产负债率 (%)6.5267.85027.83825.87317.614
带息债务/全部投入资本 (%)1.5591.71717.719--10.555
股东权益/带息债务 (%)6,024.5535,470.912455.452465.035845.387
股东权益/负债合计 (%)1,385.9491,146.241262.542296.303486.476
利息保障倍数 (X)-5.110-86.296385.20213.76417.616

营运能力分析
应收账款周转天数 (天)18.6396.71254.9430.00048.695
存货周转天数 (天)111.90144.451186.8930.000156.041